美國的心血管介入裝置市場：2012年 是由出版商Millennium Research Group在2011年12月所出版的。
這份英文市場調查報告書價格從美金5995起跳。
2011年現在，冠狀動脈支架在經皮冠狀動脈介入治療（PCI）上的使用普及，維持在創造美國心血管介入（IC）裝置整體市場大部分收益的代表性部門，並與其他心血管介入裝置相比，維持在較高的價格。但是在預測對象期間，經皮冠狀動脈介入治療（PCI）件數成長趨緩，使得負面價格設定壓力拉低平均單價，並使冠狀動脈支架的收益減少。不僅冠狀動脈支架，血管顯影診斷的減少使心血管介入裝置市場整體下滑與價格競爭，導致市場整體的緊縮。即使如此，血管內超音波（IVUS）和斷層掃描断層映像（OCT：optical coherence tomography）導管等血管內影像技術的抬頭，緩和了心血管介入裝置市場的下滑。普及的原動力在於可以精確更換支架的容易度。
本報告，探詢整體美國心血管介入裝置市場，在周全的預備調查上所獲得的基礎情報，彙整業界相關人士的直接採訪的檢證結果，由下列摘要形式闡述。
目錄
圖表一覽
報告摘要
第1章 臨床環境
- 適應症
- 診斷與症狀模式
- 治療法的概要
- 臨床指導
- 醫療報銷指導
- 國內市場概要
第2章 產品
- 概要
- 冠狀動脈支架
- PTCA氣球擴張導管
- 輔助裝置
- 血管內影像導管以及壓力導引鋼絲
- 冠狀動脈切除裝置
- 抬頭的新技術
第3章 臨床實驗
第4章 品牌以及競爭分析
- 概要
- 冠狀動脈支架市場
- PTCA氣球擴張導管市場
- 輔助裝置市場
- 血管內影像導管以及壓力導引鋼絲市場
- 冠狀動脈切除裝置市場
第5章 市場展望
- 概要
- 冠狀動脈支架市場
- PTCA氣球擴張導管市場
- 輔助裝置市場
- 血管內影像導管以及壓力導引鋼絲市場
- 冠狀動脈切除裝置市場
附錄
Abstract
In 2011, the coronary stent segment continued to represent the majority of
interventional cardiology (IC) device revenues in the US due to the widespread
use of stents in percutaneous coronary interventions (PCIs) and the devices'
relatively high price compared to other IC devices. Over the forecast period,
coronary stent revenues will, however, decrease as PCI procedure volumes will
remain flat and strong negative pricing pressure will lower average selling
prices (ASPs). Beyond coronary stents, the decrease in IC procedures as a
whole - due to decreasing diagnostic angiography volumes - and price
competition will result in a shrinking of the overall US IC device market.
Rising adoption of intravascular imaging technologies, including intravascular
ultrasound (IVUS) and optical coherence tomography (OCT) catheters, will,
however, soften the decline of the IC device market. Uptake of these devices
will be driven by their use to ensure accurate stent placement. Sales of
fractional flow reserve (FFR) guidewires will also expand due to supporting
positive clinical data. The use of this technology, which helps physicians
avoid performing unnecessary procedures, reduces the number of stents placed
per patient; the growing popularity of FFR devices will therefore restrict
stent sales to some extent over the forecast period. At the same time, ASP
growth in all segments of the US IC device market will be hindered by
competitive pressures; to attract customers, companies in the market will
engage in aggressive pricing strategies, such as offering discounts on
high-volume purchases or product bundles. While these practices will encourage
greater unit sales, ASP growth will be restricted, thereby curbing revenue
expansion. Overall, flat PCI and declining IC procedure volumes will limit
demand for IC devices, thus causing the US IC device market to decrease
moderately in value through 2016.
METHODOLOGY
RESEARCH METHODOLOGY
This report uses a number of methodologies to gather and present data and
analysis. At the outset, a large survey of secondary sources is conducted.
These sources act as the basis for the primary research stage, which builds
and enhances the quantitative and qualitative attributes of the early research.
Secondary sources include
- government publications, such as documentation from securities
commissions, health care and statistical agencies, and regulatory and patent
authorities;
- material provided by medical technology companies, including annual
reports, product brochures, and corporate profiles;
- internal databases and reports, including previous reports on similar or
related topics; and
- general Internet searches, medical literature, and newspaper and magazine
searches to identify various centers of specialization and articles that might
provide leads for primary research.
The secondary research stage builds the foundation for the primary research.
The primary research methodology has four steps:
Step 1: The first step involves an impartial scan of all the
information gathered during the secondary research stage to determine its
utility based on the specific requirements of this report. Each piece of
information is either discarded or marked as high- or low-priority and then
organized appropriately as determined by the structure and sectioning of the
report.
Step 2: At this stage, early assumptions are formed as to the
implications of the information for the various market segments. These
assumptions are then used to determine hypotheses using both inductive and
deductive approaches. On the quantitative front, these hypotheses result in
full historical and projected market data sets (market sizes - unit sales,
ASPs, and revenues - as well as market shares).
Step 3: At this stage, the research is in position for its most
important primary phase - expert interviews. Throughout the secondary research
phase, industry and medical experts are identified.
These experts are then contacted by telephone and asked to participate in
interviews on recent trends and developments in the industry. Interviews are
either conducted at the time of the initial call or scheduled at the
convenience of the expert. Interview questions are tailored to the expertise
of each particular interviewee, although in most cases, the most important
questions are asked of all experts.
The questions are largely based on the assumptions and hypotheses developed in
Step 2, which are then augmented, discarded, or adjusted based on the views
and positions put forth. Attempts are made, whenever possible, to cross-check
the views of various experts against each other and to reach positions of
consensus on issues and market numbers.
In some cases, a sample of relevant physicians is surveyed or interviewed.
Physicians are asked to comment on various issues and trends, both in their
own practice and in the overall market. The responses provided are then used
to strengthen or augment the assumptions and hypotheses developed during the
primary research phase.
Step 4: The final stage of primary research involves individual and
group analysis by Millennium Research Group. All research results are assessed
and cross-checked thoroughly to determine their validity, relevance, and
weight. From this process, qualitative conclusions are reached and data points
finalized.
MARKETRACK METHODOLOGY
Millennium Research Group's Marketrack methodology involves recruiting
hospital personnel responsible for the management of medical equipment and
procedures to participate by providing procedure volumes, device usage data,
and brand-level pricing information on an ongoing basis. Hospital respondents
include facility managers, nurses, administrators, and physicians. Information
is generally collected on a quarterly basis and includes, but is not limited
to, numbers and types of procedures performed and devices used.
FORECAST METHODOLOGY
In addition to the research methodology outlined above, the following
“bottom-up” methodology is used to develop forecast assumptions for the report.
A comprehensive breakdown of various procedures and device unit sales is
prepared using data from several sources, including professional associations,
government statistics, and private research/media sources. Industry experts
and practitioners are consulted to ensure accuracy and verify observed trends.
As a cross-check, total industry revenues available through annual reports and
other sources are compared against modeled industry revenues.
Using the best estimates of industry experts, practitioners, private
research/media sources, and inhouse experts, year-by-year growth rates and
ASPs are applied individually to each subcategory to derive forecasts. These
estimates are cross-checked by industry experts (marketing managers, product
managers, company executives, etc.) and further refined.
Overall findings are compared against market and procedure forecasts published
by other sources to ensure reasonable estimates.
Companies mentioned in this report:
- Abbott Vascular
- AngioScore
- Arrow International (a Teleflex Medical company)
- B. Braun
- Biosensors International
- BIOTRONIK
- Boston Scientific
- C. R. Bard
- Cardiovascular Systems Inc.
- CID Vascular
- Cook Medical
- Cordis
- Corindus Vascular Robotics
- Covidien
- Eurocor
- HeartFlow
- InfraReDx
- Lutonix
- Medtronic
- Merit Medical Systems
- OrbusNeich
- REVA Medical
- Sahajanand Medical Technologies
- Spectranetics
- St. Jude Medical
- Terumo Medical
- Translumina
- Tryton Medical
- Umbra Medical Products
- Vascular Solutions
- Volcano
Table of Contents
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
1.0. CLINICAL LANDSCAPE
- 1.1. Indications
- 1.1.1. Coronary Artery Disease
- 1.1.2. Unique Coronary Artery Disease Patient Subsets
- 1.1.2.1. Patients with Acute Myocardial Infarction
- 1.1.2.2. Diabetic Patients
- 1.1.2.3. Patients with Bifurcated Lesions
- 1.1.2.4. Patients with In-Stent Restenosis
- 1.1.2.5. Patients with Small Vessel Lesions
- 1.1.2.6. Femoral versus Radial Approach for Percutaneous Coronary
Intervention
- 1.2. Diagnosis and Referral Patterns
- 1.3. Procedure Overview
- 1.3.1. Interventional Cardiology Procedures
- 1.3.1.1. Diagnostic Angiography
- 1.3.1.2. Percutaneous Coronary Intervention
- 1.3.1.2.1. Stenting
- 1.3.1.2.2. Percutaneous Transluminal Balloon Angioplasty
- 1.3.1.2.3. Coronary Atherectomy
- 1.3.2. Competing Treatments
- 1.3.2.1. Medical Management
- 1.3.2.2. Noninvasive Diagnostic Angiography
- 1.3.2.3. Coronary Artery Bypass Graft Surgery
- 1.4. Clinical Guidelines
- 1.5. Reimbursement Guidelines
- 1.6. Country Overview
- 1.6.1. Demographics and Economy
- 1.6.2. Health Care System
- 1.6.3. Regulatory Environment
2.0. PRODUCTS
- 2.1. Overview
- 2.1.1. Products Covered
- 2.1.2. Differentiating Features
- 2.2. Coronary Stents
- 2.2.1. Functions
- 2.2.2. Differentiating Features
- 2.2.3. Labeled Indications
- 2.2.4. Emerging Products
- 2.3. PTCA Balloon Catheters
- 2.3.1. Functions
- 2.3.2. Labeled Indications
- 2.3.3. Emerging Products
- 2.4. Accessory Devices
- 2.5. Intravascular Imaging Catheters and Pressure Guidewires
- 2.5.1. Functions
- 2.5.1.1. Fractional Flow Reserve Guidewires
- 2.5.1.2. Intravascular Ultrasound Catheters
- 2.5.1.3. Optical Coherence Tomography Catheters
- 2.5.2. Labeled Indications
- 2.5.3. Emerging Products
- 2.6. Coronary Atherectomy Devices
- 2.6.1. Functions
- 2.6.2. Labeled Indications
- 2.7. Emerging Technologies
3.0. CLINICAL TRIALS
- 3.1. Completed Clinical Trials
- 3.2. Ongoing Clinical Trials
4.0. BRANDS AND COMPETITIVE ANALYSIS
- 4.1. Overview
- 4.1.1. Competitive Snapshot
- 4.1.2. Detailed Competitive Landscape
- 4.1.3. Market Shares
- 4.1.4. Recent Events
- 4.2. Coronary Stent Market
- 4.2.1. Competitive Snapshot
- 4.2.2. Detailed Competitive Landscape
- 4.2.3. Leading Competitors
- 4.2.4. Market Shares
- 4.3. PTCA Balloon Catheter Market
- 4.3.1. Competitive Snapshot
- 4.3.2. Detailed Competitive Landscape
- 4.3.3. Leading Competitors
- 4.3.4. Market Shares
- 4.4. Accessory Device Market
- 4.4.1. Competitive Snapshot
- 4.4.2. Detailed Competitive Landscape
- 4.4.3. Leading Competitors
- 4.4.4. Market Shares
- 4.5. Intravascular Imaging Catheters and Pressure Guidewire Market
- 4.5.1. Competitive Snapshot
- 4.5.2. Detailed Competitive Landscape
- 4.5.3. Leading Competitors
- 4.5.4. Market Shares
- 4.6. Coronary Atherectomy Device Market
- 4.6.1. Competitive Snapshot
- 4.6.2. Detailed Competitive Landscape
- 4.6.3. Leading Competitors
- 4.6.4. Market Shares
5.0. MARKET OUTLOOK
- 5.1. Overview
- 5.1.1. Market Snapshot
- 5.1.2. Detailed Market Overview
- 5.2. Coronary Stent Market
- 5.2.1. Market Snapshot
- 5.2.2. Detailed Market Overview
- 5.3. PTCA Balloon Catheter Market
- 5.3.1. Market Snapshot
- 5.3.2. Detailed Market Overview
- 5.4. Accessory Device Market
- 5.4.1. Market Snapshot
- 5.4.2. Detailed Market Overview
- 5.5. Intravascular Imaging Catheters and Pressure Guidewire Market
- 5.5.1. Market Snapshot
- 5.5.2. Detailed Market Overview
- 5.6. Coronary Atherectomy Device Market
- 5.6.1. Market Snapshot
- 5.6.2. Detailed Market Overview
APPENDIX: METHODOLOGY
APPENDIX: ACRONYMS AND INITIALISMS
APPENDIX: BIBLIOGRAPHY
LIST OF FIGURES AND TABLES
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
- Figure 1: IC Device Market, by Product Type, US (USD), 2010 - 2016
- Table 1: IC Device Market Landscape, US (USD), 2011 and 2016
- Table 2: IC Device Market Leaders, by Product Type and Revenue, US, 2011
- Table 3: Most Promising Emerging Technologies in the IC Device Market, US,
2011 - 2016
- Table 4: Expected Key Events in the IC Device Market, US, 2012 - 2016
- Table 5: Factors Impacting the IC Device Market, by Product Type, US, 2011
- 2016
- Table 6: Companies Mentioned in This Report
1.0 CLINICAL LANDSCAPE
- Table 7: Prevalence of CAD, US, 2011 and 2016
- Figure 2: Treatment Providers and Referral Patterns
- Table 8: Treatment Providers and Referral Patterns, by Treatment Phase, US
- Figure 3: CAD Treatment Options
- Table 9: Key Health and Economic Indicators, US, 2011
2.0 PRODUCTS
- Table 10: IC Device Market, by Product Type, US
- Table 11: Advantages and Disadvantages of IC Devices, by Product Type
- Table 12: Advantages and Disadvantages of Coronary Stents, by Product Type
- Table 13: Emerging Products in Development for the Coronary Stent Market,
US, 2011 - 2016
- Table 14: PTCA Balloon Functions, by Product Type and Product Features
- Table 15: Emerging Products in Development for the PTCA Balloon Catheter
Market, US, 2011 - 2016
- Table 16: Accessory Device Functions, by Product Type
- Table 17: Intravascular Imaging Catheters and Pressure Guidewire
Functions, by Product Type and Product Features
- Table 18: Emerging Technologies in Development for the IC Device Market,
US, 2011 - 2016
3.0 CLINICAL TRIALS
- Table 19: Summary of BASKET-LATE
- Table 20: Summary of COURAGE
- Table 21: Summary of HORIZONS-AMI
- Table 22: Summary of RIVAL
- Table 23: Summary of Valentines Trial
- Table 24: Summary of PEPCAD II
- Table 25: Summary of ABSORB A
- Table 26: Summary of DISCOVER-FLOW
- Table 27: Summary of SYNTAX
- Table 28: Summary of EXCEL
- Table 29: Summary of FAME
- Table 30: Summary of FAME II
- Table 31: Summary of SPIRIT PRIME
- Table 32: Summary of RESOLUTE US
- Table 33: Summary of PLATINUM
- Table 34: Summary of RESOLUTE-AC
- Table 35: Summary of PERSEUS WH
- Table 36: Summary of ABSORB EXTEND
- Table 37: Summary of PEPCAD-DEB Only
- Table 38: Summary of TRYTON
- Table 39: Summary of PRECISE
- Table 40: Summary of DeFACTO
4.0 BRANDS AND COMPETITIVE ANALYSIS
- Table 41: Leading Competitors in the IC Device Market, by Product Type, as
a % of Total, US, 2011
- Table 42: Recent Events in the IC Device Market, US, 2011
- Table 43: Leading Competitors and Brands in the Coronary Stent Market, by
Product Type, US, 2011
- Table 44: Leading Competitors in the Coronary Stent Market, by Product
Type, as a % of Total, US, 2011
- Table 45: Leading Competitors and Brands in the PTCA Balloon Catheter
Market, by Product Type, US, 2011
- Table 46: Leading Competitors in the PTCA Balloon Catheter Market, by
Product Type, as a % of Total, US, 2011
- Table 47: Leading Competitors and Brands in the Accessory Device Market,
by Product Type, US, 2011
- Table 48: Leading Competitors in the Accessory Device Market, by Product
Type, as a % of Total, US, 2011
- Table 49: Leading Competitors and Brands in the Intravascular Imaging
Catheter and Pressure Guidewire Market, by Product Type, US, 2011
- Table 50: Leading Competitors in the US Intravascular Imaging Catheter and
Pressure Guidewire Market, by Product Type, as a % of Total, US, 2011
- Table 51: Leading Competitors and Brands in the Coronary Atherectomy
Device Market, by Product Type, US, 2011
- Table 52: Leading Competitors in the Coronary Atherectomy Device Market,
by Product Type, as a % of Total, US, 2011
5.0 MARKET OUTLOOK
- Figure 4: IC Device Market, by Product Type, US (USD), 2010 - 2016
- Table 53: Factors Impacting the IC Device Market, by Product Type, US,
2011 - 2016
- Figure 5: IC Procedures, by Procedure Type, US, 2010 - 2016
- Figure 6: PCIs, by Technique, US, 2010 - 2016
- Table 54: Prevalence of CAD, US, 2011 and 2016
- Table 55: IC Procedures, by Procedure Type, US, 2010 - 2016
- Table 56: PCIs, by Technique, US, 2010 - 2016
- Table 57: PCIs, by Indication, US, 2010 - 2016
- Table 58: PCIs Performed on Patients with Diabetes and AMI, by Procedure
Type, as a % of Total, 2007 - 2011
- Table 59: PCIs Performed on Patients with Diabetes, by Procedure Type, as
a % of Total, US, 2007 - 2011
- Table 60: PCIs Performed on Patients with AMI, by Procedure Type, as a %
of Total, US, 2007 - 2011
- Table 61: IC Device Market, by Product Type, US (USD), 2010 - 2016
- Figure 7: Coronary Stent Market, by Product Type, US (USD), 2010 - 2016
- Table 62: Coronary Stent Procedures, by Technique, US, 2010 - 2016
- Table 63: Coronary Stent Procedures, by Product Type, US, 2010 - 2016
- Table 64: Coronary Stent Market, by Product Type, US (USD), 2010 - 2016
- Table 65: Coronary Stent Market Growth, by Product Type, US, 2011 - 2016
- Table 66: Coronary Stent Market, by Product Type, as a % of Total, US,
2010 - 2016
- Table 67: DES Units, by Diameter, US, 2011
- Figure 8: PTCA Balloon Catheter Market, by Product Type, US (USD), 2010 -
2016
- Table 68: PTCA Balloon Catheter Procedures, by Technique, US, 2010 - 2016
- Table 69: PTCA Balloon Catheter Market, by Product Type, US (USD), 2010 -
2016
- Table 70: PTCA Balloon Catheter Market Growth, by Product Type, US, 2011 -
2016
- Table 71: PTCA Balloon Catheter Market, by Product Type, as a % of Total,
US, 2010 - 2016
- Figure 9: Accessory Device Market, by Product Type, US (USD), 2010 - 2016
- Table 72: IC Procedures, by Procedure Type, US, 2010 - 2016
- Table 73: Accessory Device Market, by Product Type, US (USD), 2010 - 2016
- Table 74: PTCA Guidewire Market, by Product Type, US (USD), 2010 - 2016
- Table 75: PTCA Guidewire Market Growth, by Product Type, US, 2011 - 2016
- Table 76: PTCA Guidewire Market, by Product Type, as a % of Total, US,
2010 - 2016
- Table 77: Diagnostic Catheter Market, US (USD), 2010 - 2016
- Table 78: PTCA Guiding Catheter Market, US (USD), 2010 - 2016
- Table 79: Introducer Sheath Market, US (USD), 2010 - 2016
- Table 80: CTO Recanalization Device Market, US (USD), 2010 - 2016
- Figure 10: Intravascular Imaging Catheter and Pressure Guidewire Market,
by Product Type, US (USD), 2010 - 2016
- Table 81: Intravascular Imaging Catheter and Pressure Guidewire
Procedures, by Procedure Type, US, 2010 - 2016
- Table 82: IVUS Procedures, by Indication, US, 2010 - 2016
- Table 83: Intravascular Imaging Catheter and Pressure Guidewire Market, by
Product Type, US (USD), 2010 - 2016
- Table 84: IVUS Catheter Market, US (USD), 2010 - 2016
- Table 85: FFR Guidewire Market, US (USD), 2010 - 2016
- Table 86: OCT Catheter Market, US (USD), 2010 - 2016
- Figure 11: Coronary Atherectomy Device Market, by Product Type, US (USD),
2010 - 2016
- Table 87: Coronary Atherectomy Penetration into PCIs, US, 2010 - 2016
- Table 88: Coronary Atherectomies, by Product Type, US, 2010 - 2016
- Table 89: Coronary Atherectomy Device Market, by Product Type, US (USD),
2010 - 2016
- Table 90: Coronary Atherectomy Device Market Growth, by Product Type, US,
2011 - 2016
- Table 91: Coronary Atherectomy Device Market, by Product Type, as a % of
Total, US, 2010 - 2016
APPENDIX: METHODOLOGY
- Table: ICD-9-CM Procedure Codes and Descriptions
APPENDIX: ACRONYMS AND INITIALISMS
- Table: Acronyms and Initialisms
APPENDIX: BIBLIOGRAPHY
|
